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Background: Trichoderma reesei is a key cellulase source for economically saccharifying cellulosic biomass for the
production of biofuels. Lignocellulose hydrolysis at temperatures above the optimum temperature of T. reesei
cellulases (~50°C) could provide many significant advantages, including reduced viscosity at high-solids loadings,
lower risk of microbial contamination during saccharification, greater compatibility with high-temperature biomass
pretreatment, and faster rates of hydrolysis. These potential advantages motivate efforts to engineer T. reesei
cellulases that can hydrolyze lignocellulose at temperatures ranging from 60–70°C.
Results: A B-factor guided approach for improving thermostability was used to engineer variants of endoglucanase I
(Cel7B) from T. reesei (TrEGI) that are able to hydrolyze cellulosic substrates more rapidly than the recombinant
wild-type TrEGI at temperatures ranging from 50–70°C. When expressed in T. reesei, TrEGI variant G230A/D113S/D115T
(G230A/D113S/D115T Tr_TrEGI) had a higher apparent melting temperature (3°C increase in Tm) and improved half-life
at 60°C (t1/2 = 161 hr) than the recombinant (T. reesei host) wild-type TrEGI (t1/2 = 74 hr at 60°C, Tr_TrEGI). Furthermore,
G230A/D113S/D115T Tr_TrEGI showed 2-fold improved activity compared to Tr_TrEGI at 65°C on solid cellulosic
substrates, and was as efficient in hydrolyzing cellulose at 60°C as Tr_TrEGI was at 50°C. The activities and stabilities of
the recombinant TrEGI enzymes followed similar trends but differed significantly in magnitude depending on the
expression host (Escherichia coli cell-free, Saccharomyces cerevisiae, Neurospora crassa, or T. reesei). Compared to
N.crassa-expressed TrEGI, S. cerevisiae-expressed TrEGI showed inferior activity and stability, which was attributed to
the lack of cyclization of the N-terminal glutamine in Sc_TrEGI and not to differences in glycosylation. N-terminal
pyroglutamate formation in TrEGI expressed in S. cerevisiae was found to be essential in elevating its activity and
stability to levels similar to the T. reesei or N. crassa-expressed enzyme, highlighting the importance of this ubiquitous
modification in GH7 enzymes.
Conclusion: Structure-guided evolution of T. reesei EGI was used to engineer enzymes with increased thermal stability
and activity on solid cellulosic substrates. Production of TrEGI enzymes in four hosts highlighted the impact of the
expression host and the role of N-terminal pyroglutamate formation on the activity and stability of TrEGI enzymes.
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Figure 1 Crystal structure of Endoglucanase I from Trichoderma
reesei. Disulfide bonds are shown in blue. N-glycosylation sites are shown
in magenta. Mutagenesis sites are shown in red and are labeled as follows:
A (aa 284–287), B (aa 301–302), C (aa 113, 115), D (aa 238), E (aa 230), F
(aa 323), and G (aa 291). Mutations at site C and site E resulted in
improved TrEGI enzyme variants. PDB code 1EG1.
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Efficient saccharification of cellulosic biomass to fermentable
sugars is necessary for economical production of second
generation biofuels. Several enzymes (exoglucanases, endo-
glucanases, oxidative enzymes, and β-glucosidases) act in
concert to hydrolyze cellulose to glucose. The industrially
employed filamentous fungus Trichoderma reesei has been
evolved for cellulase production and is capable of secreting
large quantities of cellulolytic enzymes at a relatively low
cost [1,2]. These include two exoglucanases, Cel7A and
Cel6A (CBH I and CBH II), which represent 50% and 20%
of the total cellulase content, respectively, four endogluca-
nases, Cel7B (EGI), Cel5A (EGII), Cel12A (EGIII), and
Cel45A (EGV) that represent approximately 15%, 10%, 1%,
and <1% of the total cellulase content, respectively, and sev-
eral lytic polysaccharide monooxygenases [3,4].
Lignocellulose hydrolysis at relatively high temperatures
(above 50°C, which is near the optimum for many fungal
cellulases) may offer potential advantages, including reduced
solution viscosity at high-solids loadings (>20 wt%), lower
risk of microbial contamination during saccharification,
greater compatibility with high-temperature pretreatments,
and potentially faster rates of hydrolysis [5]. The short half-
lives of T. reesei cellulases at temperatures above 50°C, to-
gether with very low expression levels of thermophilic cellu-
lases (typically less than 100 mg/L, compared to over 150
gm/L for T. reesei cellulases) [6], motivates the development
of thermostable T. reesei cellulases that can hydrolyze ligno-
cellulose efficiently at temperatures beyond 50°C. T. reesei
endoglucanase I (TrEGI) is known to randomly cleave in-
ternal cellulosic bonds, thereby creating shorter cellulosic
chains. Recent studies on optimizing the components of cel-
lulase systems have underscored the importance of having
TrEGI comprise a high fraction of the cellulase mixture
(25–35%) in order to efficiently hydrolyze pretreated ligno-
cellulosic biomass [7,8].
TrEGI has a bimodular structure with a 375-amino-acid
(aa) catalytic domain (CD, Figure 1) attached to a 35-aa
carbohydrate-binding module (CBM) via a 26-aa linker.
TrEGI has 11 disulfide bonds (8 in the CD [highlighted in
blue in Figure 1] and 3 in the CBM), 6 N-glycosylation sites
in the CD (highlighted in magenta in Figure 1), and a linker
region rich in serine and threonine that are potential O-
glycosylation sites. It was selected for engineering enhanced
thermostability because of its importance in cellulose hy-
drolysis and the availability of its crystal structure [9].
Although protein engineering has been used to improve
the thermostability of numerous cellulases [10-13], there
are no reports on improving the thermostability or in-
creasing the optimal temperature of TrEGI. In this study,
we employed a B-factor guided approach [14] to engineer
thermostable variants of TrEGI using E. coli cell-free pro-
tein synthesis due its ease and throughput (Figure 2).
Many thermostable mutants of TrEGI identified usingcell-free protein synthesis were subsequently expressed in
the fungal hosts S. cerevisiae, N. crassa, and T. reesei to
better mimic the properties of the native TrEGI enzyme in
terms of folding and glycosylation (Figure 2). TrEGI vari-
ants, particularly G230A/D113S/D115T, were more stable
compared to their recombinant wild-type versions when
both the variant and wild-type were expressed in S. cerevi-
siae, N. crassa, or T. reesei, indicating that the positive in-
fluence of these mutations on stability translates across
different expression hosts. However, the S. cerevisiae-
expressed enzymes were inferior in terms of activity and
stability compared to the same enzymes expressed in T.
reesei or N. crassa, which we attribute to the lack of
cyclization of the N-terminal glutamine of TrEG1
expressed in our S. cerevisiae system.
Results and discussion
B-factor guided mutagenesis
Our efforts to improve the thermostability of TrEGI entailed
a B-factor guided approach (B-FIT method) [14]. The B-
factor is a measure of the average deviation of a given resi-
due from its mean position in the crystal structure. Residues
having the highest average B-factors (obtained from the
crystal structure) correspond to the most flexible sites in the
Figure 2 Engineering thermostable Endoglucanase I from Trichoderma reesei.
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mostability. This strategy is based on the premise that the
thermostability of a mesophilic enzyme can be enhanced by
increasing its rigidity at the most flexible sites in its struc-
ture. Examples of B-factor guided mutagenesis to increase
thermostability include a Bacillus subtilis lipase (ΔT6050 of
42°C) [14] and a Pseudomonas fluorescens esterase (ΔT 6050
of 9°C) [15], where ΔT 6050 corresponds to the change in
temperature at which the enzyme loses half its activity
after an hour of incubation.
Using the crystal structure of the TrEGI catalytic do-
main (Figure 1), we identified the 20 amino acids with
the highest B-factors. These amino acids were grouped
in seven sites (Figure 1, in red) comprising one or more
amino acids [Site A (aa 284–287), Site B (aa 301–302),
Site C (aa 113, 115), Site D (aa 238), Site E (aa 230), Site
F (aa 323), Site G (aa 291)], and were chosen for site-
saturation mutagenesis. Amino acids with high B-
factors that were in close proximity to the N- or C-
terminus, disulfide bridges, or N-glycosylation sites in
the TrEGI crystal structure were not selected because
they could interfere with disulfide-bond formation or
lead to false positives due to compensation for non-
glycosylation in a bacterial expression system.
A modification of the cell-free protein synthesis
protocol developed in our laboratory [16] was used to
express TrEGI in an active, soluble form (Additional file
1: Figure S1). The stability of the cell-free expressed
TrEGI is comparable to TrEGI expressed in E. coli [17],
but is considerably reduced compared to the native en-
zyme expressed in T. reesei [18]. Although cell-freeprotein synthesis yielded an inferior TrEGI enzyme, we
proceeded to use cell-free expression as a tool to rapidly
screen mutants of TrEGI, with the assumption that the ef-
fect of mutations imparting thermostability will be con-
served upon expression in fungal hosts such as T. reesei.
The protocol for screening and selection of mutant
TrEGI enzymes is shown in (Additional file 1: Figure S2).
Mutagenesis and screening of 11,000 mutants at sites A-G
generated ~500 mutants with higher activity toward
carboxymethyl cellulose (CMC) after pre-incubation at
50°C for 45 min than the wild-type TrEGI expressed
using cell-free synthesis. Sequencing the 70 mutants
that showed highest activities after the heat treatment
revealed that all but six mutants had a mutation at site
E (amino acid 230, glycine). Alanine, arginine, serine,
threonine, leucine, lysine, glutamic acid, glutamine, and
methionine substitutions at this position all imparted
improved thermostability. In addition, we found muta-
tions at site C (amino acids D113, D115) that gave rise
to more stable variants of TrEGI. Amino acid changes
at this site for these TrEGI mutants were D113S/D113T
and D115L/D115G. Even though the D113L/D115G
mutant had greater thermostability at 50°C, it was not
pursued further because it had low specific activity rela-
tive to wild-type TrEGI expressed using cell-free synthe-
sis. Since the single mutants (D113S, and D115T) were
not isolated during the screening process that covered
>95% of all possible amino acid combinations at site C
[19], it is highly likely that mutations at both these sites
need to be present simultaneously to afford increased
stability.
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The activities of some of these thermostable TrEGI mutants
toward CMC, based on the amount of reducing sugar re-
leased before and after exposure to 50°C for various times,
are summarized in Figure 3. Combining mutations at G230
with mutations at sites D113 and D115 resulted in triple
mutant enzymes (G230X/D113S/D115T, X =K, A, S, R, E,
L, T, M; Figure 3) that were more active at 50°C than either
of the engineered parents (Figure 3). All the triple mutants
showed higher specific activity at 50°C on CMC compared
to the wild-type TrEGI expressed using cell-free synthesis at
50°C; mutants G230K/D113S/D115T and G230T/D113S/
D115T exhibited ~5 fold improvement in specific activity.
The engineered TrEGI enzymes also showed higher ac-
tivity on solid substrates: Avicel and ionic-liquid pretreated
Avicel (IL-Avicel) (Additional file 1: Figure S3). All of the
engineered enzymes showed ~2-fold higher activity for Avi-
cel hydrolysis (Additional file 1: Figure S3A) and ~5-fold
improvement for IL-Avicel hydrolysis (Additional file 1:
Figure S3B, G230X/D113S/D115T, X =K, A, S, R) at 50°C
relative to the wild-type TrEGI expressed by cell-free syn-
thesis. Many of these TrEGI mutants were active against
both substrates at 55°C, conditions under which the wild-
type TrEGI expressed by cell-free synthesis was essentially
inactive.
Characterization of Trichoderma reesei endoglucanase I
variants expressed in S. cerevisiae
Considering the impact of proper folding and glycosyla-
tion on the stability, activity, and structure of proteinsFigure 3 Activity of T. reesei endoglucanase I mutants at 50°C on CMC
expressed using cell-free protein synthesis and were used without any pur[20-24], we sought to express TrEGI enzymes in a fun-
gal host. Because recombinant expression of proteins in
filamentous fungi is typically tedious, time-consuming,
and not amenable to high-throughput, we used S. cere-
visiae [25] as an intermediate fungal expression host to
evaluate the stability and activity of the engineered
TrEGI triple mutants (enzymes expressed in S. cerevi-
siae are designated Sc_TrEGI). Of all the triple mutants
tested (G230X/D113S/D115T, X = K, A, S, R, E, L, T,
M), only five of the TrEGI mutants were expressed in
active and soluble forms (G230X/D113S/D115T, X = A,
E, R, L, T). The enzymes were secreted from yeast in a
hyperglycosylated state (MW of 70–200 KDa) as ob-
served previously [26,27], and thus were treated with an
endoglycosidase (PNGase F) that cleaves N-glycans, re-
ducing the molecular weight to 54–56 kDa (TrEGI MW
is 46 kDa based on aa sequence, with glycans contribut-
ing 8–10 kDa), which nearly matches the molecular
weight of the natively-expressed TrEGI enzyme (50–
55 kDa) [26].
Many of these TrEGI mutants exhibited higher hydro-
lytic activities on soluble (MU-cellobiose) and solid sub-
strates (Avicel and IL-Avicel) compared to Sc_TrEGI
(Additional file 1: Figure S4) at 50–65°C. The mutant
G230A/D113S/D115T Sc_TrEGI (Figure 4D and 4E) is >
2.5-fold better than Sc_TrEGI (Figure 4A and 4B) at
hydrolyzing Avicel at 60°C and IL-Avicel at 65°C. In
addition, the activity of G230A/D113S/D115T Sc_TrEGI
at 60°C against Avicel and IL-Avicel is similar to that of
Sc_TrEGI at 50°C on these substrates. Hence, B-factor
guided engineering of TrEGI provided variants with. Error bars represent one standard deviation. TrEGI proteins were
ification.
Figure 4 Temperature activity profile of wild-type T. reesei endoglucanase I (A-C) and G230A/D113S/D115T mutant (D-F) on Avicel (A,D),
IL-Avicel (B,E), and MU-Cellobiose (C,F) expressed in S. cerevisiae, N. crassa, T. reesei , and S. cerevisiae followed by N-terminal cyclization of the
wild-type TrEGI with gutaminyl cyclase. Error bars represent one standard deviation. Assays were carried out with purified TrEGI proteins (>95% pure
based on SDS-PAGE analysis).
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lar to the activity of Sc_TrEGI toward these same sub-
strates at 50°C.
All of the engineered triple mutants expressed in S.
cerevisiae exhibited higher apparent melting tempera-
tures (Tm = 58–61°C; measurements were performed as
described in Methods using differential scanning calor-
imetry) than Sc_TrEGI (Tm = 57°C). Mutant G230A/
D113S/D115T Sc_TrEGI (Tm = 61°C, Table 1) showed a
~4°C increase in apparent melting temperature overSc_TrEGI. No significant difference in half-life at 70°C
was observed between Sc_TrEGI and this mutant
(Table 1). It is important to note that our initial efforts
included expressing the TrEGI enzymes bearing a C-
terminal his6 tag, which lowered their activity on Avicel
(up to 3-fold; compare Additional file 1: Figure S4A and
Figure S5), but had little effect on their activity on IL-
Avicel (data not shown). This result suggests abrogated
binding to Avicel of TrEGI enzymes bearing a C-
terminal his6 tag.
Table 1 Biochemical characterization of TrEGI expressed in different hosts
Expression host Enzyme Tm (°C) t1/2 (hr)
50°C 60°C 65°C 70°C
S. cerevisiae WT 57 - - - 3 (0.4)
S. cerevisiae G230A/D113S/D115T 61 - - - 3.7 (0.5)
S. cerevisiae WT + Glutaminyl Cyclase 65 - - - -
N. crassa WT 65 >5 days 70.6 (3.5) 4.0 (0.2) 3.3 (0.1)
N. crassa G230A/D113S/D115T 68 >5 days 176 (16) 3.3 (0.3) 3.5 (0.4)
T. reesei WT 65 >5 days 74 (2.5) 5.8 (0.6) 6.2 (0.4)
T. reesei G230A/D113S/D115T 68 >5 days 161 (5) 6.2 (0.7) 6.4 (0.3)
Tm is the apparent melting temperature for the enzyme, and t1/2 is half-life in hours. - = Not determined. Errors are reported in parentheses and represent one
standard deviation for measurements. Apparent melting temperature data for Sc_TrEGI (with and without glutaminyl cyclase treatment) and Tr_TrEGI are
shown in (Additional file 1: Figure S9). Apparent melting temperature data are not shown for other TrEGI enzymes. Half-life measurements for T. reesei- and
N. crassa-expressed enzymes are shown in (Additional file 1: Figure S6 and Figure S7), respectively. Half-life measurements for S. cerevisiae-expressed TrEGI
enzymes are not shown.
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variants expressed in the filamentous fungi N. crassa and
T. reesei
Sc_TrEGI showed a much lower apparent melting tem-
perature (Tm = 57°C) and temperature optimum (50°C)
compared to the native TrEGI (Tm ~65°C, Topt 60°C) [18],
which could be due to non-optimal folding and/or aberrant
glycosylation of TrEGI when expressed in S. cerevisiae. In
order to investigate these possibilities, and to compare the
properties (activity and stability) of the engineered TrEGI
enzymes to the native TrEGI, we pursued TrEGI expression
in T. reesei. Thus the wild-type TrEGI and the best mutant
(G230A/D113S/D115T TrEGI) were expressed in T.
reesei QM9414. In addition, our interest in evaluating
alternative filamentous fungal systems for cellulase ex-
pression prompted us to express TrEGI enzymes (wild-
type, G230A/D113S/D115T, and G230E/D113S/D115T)
in the filamentous fungus N. crassa, which is closely re-
lated to T. reesei. TrEGI enzymes (wild-type or G230A/
D113S/D115T) expressed in T. reesei and N. crassa were
found to have identical temperature optima on MU-
cellobiose (Figure 4C, 4F), and apparent melting tem-
peratures (Table 1), which in the case of wild-type
enzyme (Tr_TrEGI and Nc_TrEGI) is also identical to
the values reported previously for the native TrEGI. Fur-
thermore, little difference was observed between their
activities on solid substrates Avicel (Figure 4A) and IL-
Avicel (Figure 4B), thus validating N. crassa as a suitable
surrogate of T. reesei for TrEGI production.
G230A/D113S/D115T Tr_TrEGI showed similar or
higher activity on solid substrates (Figure 4D and 4E) than
Tr_TrEGI when assayed at 50–70°C (Figure 4A and 4B);
specifically, a ~2-fold increase in activity was observed at
65°C. In addition, G230A/D113S/D115T Tr_TrEGI showed
similar hydrolytic activity on solid substrates at 60°C as the
Tr_TrEGI at 50°C. As expected, similar improvements were
also observed for N. crassa-expressed TrEGI variants.Hence, B-factor guided engineering of TrEGI provided vari-
ants with hydrolytic activities on Avicel and IL-Avicel at 60°
C similar to the activity of Tr_TrEGI toward these same
substrates at 50°C.
G230A/D113S/D115T Tr_TrEGI (Tm= 68°C), G230A/
D113S/D115T Nc_TrEGI (Tm= 68°C), and G230E/D113S/
D115T Nc_TrEGI (Tm= 68°C) showed a 3°C increase in
apparent melting temperature (Table 1 and, Additional
file 1: Table S1) compared to Tr_TrEGI or Nc_TrEGI
(Tm = 65°C). In order to assess whether the thermostable
mutants also show improved half-lives over the wild-type
TrEGI, half-lives of the thermostable mutant G230A/
D113S/D115T TrEGI and the wild-type TrEGI (T. reesei-
or N. crassa-expressed) were measured at 50°C, 60°C, 65°C
and 70°C (Table 1 and Additional file 1: Figure S6-S7).
Although the half-life for TrEGI enzymes at 50°C was too
long (>5 days) to distinguish any gains made at this
temperature (data not shown), the G230A/D113S/D115T
TrEGI variant showed a >2-fold increase in half-life at 60°C
compared to the corresponding recombinant (T. reesei or
N. crassa) wild-type TrEGI (Table 1). The improved half-
life (t1/2 = 161 hr) of the G230A/D113S/D115T Tr_TrEGI
variant at 60°C results in improved or comparable perform-
ance of this mutant in biomass saccharification carried out
at 60°C compared to the performance of Tr_TrEGI at 50°C
(Figure 4A, B, D and E). We also expect that the in-
creased stability and half-life of the G230A/D113S/
D115T Tr_TrEGI at temperatures such as 60°C will cor-
relate with improved half-life at lower temperatures
(≤60°C) compared to Tr_TrEGI. The half-lives of both
these enzymes were significantly shorter (~3–6 hr)
(Table 1) at higher temperatures (65°C and 70°C). It is
surprising that little or no difference was found between
the half-lives of G230A/D11S/D115T TrEGI and the
wild-type enzyme (T. reesei- or N. crassa-expressed) at
either 65°C or 70°C (Table 1), which may reflect a shift
in the inactivation mechanism(s) with temperature
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cosylation patterns as observed previously with other β-
sandwich or multi-domain proteins [28,29].
Impact of N-terminal pyroglutamate on activity and
stability of T. reesei endoglucanase I
TrEGI and G230A/D113S/D115T TrEGI expressed in
both T. reesei and N. crassa were found to have much
higher Tm values (7–8°C difference) than their S. cerevi-
siae-expressed counterparts (Table 1). In addition, they
were up to 3.6-fold more active on Avicel (Figure 4A
and D) at 50–65°C and up to 2.5-fold more active on IL-
Avicel (Figure 4B and E) at 50–65°C compared to their
counterparts expressed in S. cerevisiae. Given the simi-
larity of molecular weights of the TrEGI glycoforms
expressed in S. cerevisiae and N. crassa (Additional file
1: Figure S8), the lower stability and activity of S. cerevi-
siae TrEGI could potentially be due to non-optimal fold-
ing (due to protein modifications or lack thereof ) and/or
incorrect disulfide formation upon expression in S. cere-
visiae. In this connection, we investigated the role of N-
terminal pyroglutamate observed in the T. reesei EGI
crystal structure.
The available crystal structure of T. reesei EGI (pdb
code 1EGI) [7] reveals a buried N-terminal pyrogluta-
mate in the natively-expressed enzyme resulting from
the cyclization of the N-terminal glutamine. We hypoth-
esized that the lack of this N-terminal glutamine
cyclization (confirmed by N-terminal sequencing of S.
cerevisiae-expressed TrEGI enzyme) in S. cerevisiae-
expressed enzyme would most likely result in non-
optimal protein structure and contribute to the observed
decreased stability and activity compared to the T. ree-
sei-expressed enzyme. Glutaminyl cyclases (E.C. 2.3.2.5)
are known to catalyze the irreversible lactamization of a
N-terminal glutamine to a hydrophobic pyroglutamate
in many proteins and peptides [30]. Using a human glu-
taminyl cyclase enzyme [31] we cyclized the N-terminal
glutamine residue of Sc_TrEGI to a pyroglutamate, as
evidenced by a blocked N-terminal sequence, typical of
proteins/peptides with N-terminal pyroglutamate [32].
Treating Sc_TrEGI with the human glutaminyl cyclase
substantially increased its activity on solid substrates
compared to the corresponding enzyme without glutaminyl-
cyclase treatment (Figure 4A-B), and shifted its temperature
optimum from 50°C to 60°C on soluble substrates
(Figure 4C). The activity of the glutaminyl-cyclase treated
Sc_TrEGI on Avicel and IL-Avicel is similar if not identical
to its counterpart expressed in T. reesei or N. crassa
(Figure 4A-B).
The increased stability of Sc_TrEGI from N-terminal glu-
tamine cyclization was evaluated by measurements of appar-
ent melting temperatures (Additional file 1: Figure S9).
Glutaminyl-cyclase treated Sc_TrEGI (Tm= 65°C) showedan ~8°C increase in apparent melting temperature com-
pared to the corresponding uncyclized version (Table 1).
The apparent melting temperature of Sc_TrEGI upon
cyclization (Table 1) was identical to that of Tr_EGI (Tm =
65°C). The large increase in Tm upon N-terminal glutamine
cyclization indicates that the lower stability of the S. cerevi-
siae enzymes is due to the uncyclized N-terminal glutamine.
In addition, it is worth noting that the differences in glyco-
sylation between Sc_TrEGI and Nc_TrEGI (Additional
file 1: Figure S8) are irrelevant to the activity and stability
differences between these enzymes in comparison to the
cyclization of the N-terminal glutamine. Recently our group
also demonstrated a similar increase in stability and activity
upon cyclization of N-terminal glutamine to pyroglutamate
in S. cerevisiae-expressed Talaromyces emersonii Cel7A [33].
The ubiquitous presence of the N-terminal pyroglutamate
in GH7 enzymes (Cel7A and Cel7B), along with its role in
imparting high stability/activity for these enzymes, highlights
the importance of N-terminal glutamine cyclization for
achieving high-efficiency cellulases.
Impact of mutagenesis and expression host on activity
and stability of T. reesei endoglucanase I
Combinations of TrEGI mutations at amino acids G230,
and D113/D115 identified using the B-factor method re-
sulted in improved TrEGI enzymes irrespective of the ex-
pression host for the enzyme. In particular, TrEGI mutant
G230A/D113S/D115T showed improved activity on solid
substrates as well as improved thermostability for each ex-
pression host when compared to wild-type TrEGI enzyme
expressed in the same host. These mutations may rigidify
the mobile portions of the TrEGI enzyme, and thus en-
hance its stability. In particular, it is likely that the mutation
at G230, which is located on a solvent exposed loop, im-
parts improved stability by reducing the entropy (rigidify-
ing) of the (partially) unfolded TrEGI, a well-known
mechanism for improving protein stability by replacing
conformationally flexible residues such as glycine (located
in loops or secondary structural elements) with more rigid
residues such as alanine [34,35]. Removal of unfavorable
electrostatic interactions involving negative charges on
D113/D115 in the wild-type enzyme could also lead to
increased stability [36]. A small difference in mass was
observed between Nc_TrEGI and G230A/D113S/D115T
Nc_TrEGI (mass difference = 0–2 Da, Additional file 1:
Figure S8 C/D) and between Sc_TrEGI and G230A/D113S/
D115T Sc_TrEGI (mass difference = 2–59 Da, Additional
file 1: Figure S8 A/B), after accounting for the mass differ-
ence resulting from the G230A/D113S/D115T mutation.
This shows that there is little or no difference in the extent
of glycosylation (total glycan content = 8–10 kDa) between
the wild-type TrEGI and the mutant G230A/D113S/D115T
TrEGI when they are expressed in the same fungal host.
Thus, the improved stability of G230A/D113S/D115T
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either N. crassa or S. cerevisiae is due to the G230A/
D113S/D115T mutation and not due to changes in
glycosylation.
The specific activity of TrEGI enzymes (wild-type and
G230A/D113S/D115T) on solid substrates was dramatic-
ally altered upon expression in different hosts (cell-free, S.
cerevisiae, N. crassa, and T. reesei) with T. reesei or N.
crassa producing the most active enzymes on Avicel and
IL-Avicel (Figure 4). Glycosylation of TrEGI enzymes ren-
ders them more thermostable compared to their cell-free
expressed counterparts, which is consistent with previous
reports showing the importance of glycosylation in protein
thermostability [20-22,24]. The cyclization of N-terminal
glutamine to a pyroglutamate in S. cerevisiae expressed
TrEGI resulted in a TrEGI enzyme with near identical
properties to the natively expressed enzyme.
Conclusions
Using B-factor guided mutagenesis,T.reesei endoglucanase
I variants were developed that were up to 2-fold more ac-
tive on solid cellulosic substrates at 65°C than the recom-
binant wild-type enzyme expressed in the same hosts, and
exhibited the same activity at 60°C as the recombinant
wild-type enzyme at 50°C. The most stable TrEGI mutant
G230A/D113S/D115T showed a ~3°C increase in Tm, as
well as more than 2-fold improved half-life at 60°C over
the native TrEGI. Amino acid changes at G230 coupled
with the D113S/D115T double mutation in TrEGI gave
rise to variants with improved thermostability and activity
at 50–70°C, irrespective of their expression host. However,
the stability and activity of the TrEGI enzymes varied sig-
nificantly when expressed using E. coli cell extract, S. cere-
visiae, N. crassa, or T. reesei. TrEGI variants expressed in
N. crassa or T. reesei yielded the most active and stable
TrEGI enzymes and S. cerevisiae yielded inferior TrEGI
enzymes. Cyclization of N-terminal glutamine to a pyro-
glutamate in S. cerevisiae-expressed TrEGI improved its
properties to closely match those of the native enzyme,
highlighting the importance of this ubiquitous modifica-
tion in Cel7B enzymes. In this study we show that a non-
glycosylating host can be used to screen and discover ther-
mostability imparting mutations in fungal enzymes that
result in improved enzymes irrespective of the protein
production host. The choice of host for protein engineer-
ing of cellulases may not be as critical as the protein pro-
duction host, which plays a major role in determining the
properties of the expressed enzymes.
Methods
All experiments were carried out using either purified
TrEGI enzymes (when expressed in S. cerevisiae, N.
crassa, or T. reesei) or TrEGI enzymes expressed via cell-
free protein synthesis without any purification. Purity ofpurified enzymes (>95%) was determined using SDS-
PAGE analysis with Coomassie blue dye staining.
Construction of plasmid bearing T. reesei endoglucanase I
Gene for the T. reesei endoglucanse I (cel7b, UniProt No.
P07981) synthesized with E. coli codon bias was purchased
from GenScript (Genscript Corporation, Piscatway, NJ,
USA). The structural gene of cel7b was PCR-amplified from
plasmid pUC57-P07981 by using the forward primer (5’-
AAAAAACATATG CAACAACCGGGCACCTCC-3′) and
reverse primer (5′-AAAAAAGTCGACTTACAGACATTG
CGAGTAGTA-3′). PCR product was then cloned into
pIVEX2.4d vector (Roche Applied Science) after a double
digestion with NdeI and SalI to generate plasmid,
pIVEX2.4d-TrEG1.
Preparation of S30 cell-extract
The cell-extracts were prepared as reported previously
[16]. To exhaust the reducing activity of cell-extract, the
S30 extract was incubated with 10 mM oxidized gluta-
thione for 2 hrs at 30°C. The residual glutathione mole-
cules were removed by dialyzing the treated extract
against 200 volumes of buffer C (buffer A without DTT
and 2-ME) for 3 hrs at 4°C. The resulting extract was di-
vided into small aliquots and stored at −80°C before
using it for cell-free protein synthesis.
Site directed mutagenesis of T. reesei endoglucanase I
Site directed mutagenesis at amino acids 238, 291, and
323 of T. reesei EGI (pIVEX2.4d-TrEG1 as template plas-
mid) was performed using the site directed mutagenesis
kit (Stratagene) by following the manufacturers protocol
with primers shown in Additional file 1: Table S2. Muta-
genesis at sites with amino acids 230, 113 and 115, 284–
287, and 301–302 of T. reesei EGI (pIVEX2.4d-TrEG1 as
template plasmid) was performed using Overlap Extension
PCR. All PCR reactions were carried out using Pfu DNA
polymerase (Stratagene, La Jolla, CA). The plasmids were
transformed into electrocompetent XL1 Blue cells and
plated. Colonies were picked and transferred into 96-well
plates using a colony picker (Qpix) and grown overnight
at 37°C in 10% glycerol containing LB medium. For site A,
~3000 colonies were picked, corresponding to ~2% cover-
age; for all other sites, colonies corresponding to >95%
coverage of sequence space were picked and grown over-
night in 96-well plates (~3000 colonies for sites B and C,
and ~500 colonies for sites D-G).
Cell-free protein synthesis
Overnight culture bearing the mutant T. reesei EGI gene
was used as a template for the PCR reaction. TrEGI DNA
amplified by PCR using T7 fwd and T7 rev primers served
as template for protein synthesis. The standard reaction
mixture for cell-free protein synthesis consisted of the
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Hepes-KOH (pH 7.5); 1.2 mM of ATP; 0.85 mM each of
CTP, GTP, and UTP; 0.17 mg/mL of E.coli total tRNA mix-
ture (from stain MRE600); 90 mM of potassium glutamate;
80 mM of ammonium acetate; 12 mM of magnesium acet-
ate; 34 μg/mL of L-5-formyl-5, 6, 7, 8-tetrahydrofolic acid
(folinic acid); 2.0 mM each of all 20 amino acids; 2% PEG
(8000); 67 mM of creatine phosphate (CP); 3.2 μg/mL of
creatine kinase (CK); 2.5 mM oxidized glutathione; 2.5 mM
reduced glutathione; 16.7 μg/mL of PCR product; 27%(v/v)
of S30-GroEL/ES cell-extract. The cell-free reaction was
conducted at 30°C for 2 hours. For determining the amount
of the protein synthesized using the cell-free synthesis,
10 μM of L-[U-14C] Leucine (11.3 GBq/mmol, Amersham
Biosciences) was also added to the cell-free reaction. To
analyze the solubility of cell-free expressed protein, the cell-
free mixture was centrifuged at 15,000 rpm for 10 min at
4°C. The soluble amount of synthesized protein was deter-
mined by analyzing the supernatant of the centrifugation.
The amount of each cell-free synthesized cellulase was esti-
mated from the TCA-insoluble radioactivity using a liquid
scintillation counter (Tri-Carb 2810TR Liquid Scintillation
Analyzer, Perkin-Elmer Inc.).Screening T. reesei endoglucanase I mutants for
improved thermostability/activity
Two μL of 1 M sodium acetate buffer pH 4.85 was added to
15 μL of cell-free expressed TrEGI mutant to lower the pH
to 5. TrEGI mutant was then heated to 50°C for 30 mins
after which 1 μL was spotted on CMC-agar plate (1%CMC,
1.5% agar, 50 mM pH 4.85 Acetate buffer) and incubated
overnight (12–16 hr) at 50°C. The CMC-agar plates were
stained with 15 mL of 1% congo red for 5 mins. The plates
were then analyzed for presence of clearing zones, which
represented active enzymes (hits). All experiments were car-
ried out using TrEGI enzymes expressed using cell-free pro-
tein synthesis without any purification.Measuring the thermostability of Trichoderma reesei
endoglucanase I
To measure the thermostability of TrEG1, 10 μL of the
cell-free synthesized TrEG1 (20 pmol) was mixed with
10 μL of 200 mM of sodium acetate buffer (pH 4.85).
After incubating the enzyme mixture at 50°C with differ-
ent incubation time points (0, 15, 30, 45, 60 min), 80 μL
of 1.25% (w/v) CMC containing 100 mM sodium acetate
buffer (pH 4.85) was added into the heat-pretreated en-
zyme mixture to start hydrolysis reaction for 1 hr at 50°
C. The reducing sugar concentration was measured by
the DNS assay as described previously [16]. All experi-
ments were carried out in triplicate using TrEGI en-
zymes expressed via cell-free protein synthesis without
any purification.Endoglucanase activity measurement on solid cellulosic
substrates
All cellulolytic assays for solid substrates were carried out
in quadruplicate in 96-well plates in a final volume of
70 μL containing 1% (w/v) substrate, 100 mM sodium
acetate buffer pH 4.85, 0.2 μM of the cellulase at 50–70°C.
The 96-well plates were sealed with aluminum foil and in-
cubated without shaking in a thermocycler with a heated
top to minimize evaporation. Cellulase activities were
measured for Avicel, and ionic-liquid pretreated Avicel
(IL-Avicel). The mixtures were incubated at 50–70°C for
15 h after which they were cooled to 4°C prior to measur-
ing the amount of soluble reducing sugar released using
the glucose oxidase-peroxidase assay as described previ-
ously [16]. IL-avicel was prepared as described previously
[16]. All experiments were carried out using either puri-
fied TrEGI enzymes (when expressed in S. cerevisiae, N.
crassa, or T. reesei) or TrEGI enzymes expressed via cell-
free protein synthesis without any purification. Enzyme
purity (>95%) was determined using SDS-PAGE analysis
with Coomassie blue dye staining.
Expression of T. reesei endoglucanase I in S. cerevisiae
For production of T. reesei EGI and engineered mutants in
S. cerevisiae, the corresponding genes (E. coli codon opti-
mized as described above) were amplified from pIVEX
2.4d vector and were cloned with and without a his6 tag
on the C-terminus in pCu424 vector [37]. An engineered
α-factor AppS4 [38] prepro leader sequence was appended
onto the N-terminus of the genes to enable secretion of
the enzyme. pCu424 containing T. reesei EG1 gene was
transformed into S. cerevisiae strain YVH10 [39] with add-
itional PMR1 knockout using the LiAc method [40]. For
expression, a saturated YPD medium preculture was used
to inoculate 1 L selective medium (SC-Trp) and grown for
three days at 30°C. The culture was spun down at 4000 g
for 5 min and resuspended in YPD medium supplemented
with 500 μM CuSO4 for a three-day induction at 25°C.
Culture supernatant was concentrated to ~100 mL
(10 kDa cut-off) prior to purification. TrEGI bearing the
his6 tag was purified from culture supernatant using Ni-
affinity chromatography. TrEGI without the his6 tag was
purified from culture supernatant as described below for
N. crassaTrEGI.
Deglycosylation of T. reesei endoglucanase I expressed in
S. cerevisiae
Three to five mg of purified T. reesei EG1 expressed in
S. cerevisiae was incubated in pH 7.0, 25 mM phosphate
buffer along with 200 units of PNGase F (NEB) at 30°C
for 18 h following which an additional 100 units of
PNGase F were added and incubated for another 24 h.
PNGase F treated T. reesei EG1 was purified using gel
filtration chromatography.
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expressed in S. cerevisiae, N. crassa, and T. reesei
To measure the temperature optima, TrEG1 and the
mutants expressed in S. cerevisiae (glycosylated versions)
and T. reesei were assayed for 10 min at different tem-
peratures (40°C–65°C) using 1 mM MU-cellobiose in
100 mM sodium acetate buffer (pH 4.85) as the sub-
strate in a 100 μL reaction volume in a PCR thermocy-
cler. The reaction was quenched by adding 5 μL of the
reaction mixture to 145 μL 110 mM CAPS buffer,
pH 10.8. Activity was determined by measuring the
fluorescence of methyl umbelliferone released. The
TrEGI enzyme concentration ranged from 0.1–0.5 μM
for initial-rate measurements. All experiments were car-
ried out in quadruplicate. All experiments were carried
out using purified enzymes.
Half-life measurements of T. reesei endoglucanase I
expressed in S. cerevisiae, N.crassa, and T. reesei
TrEGI enzymes (1 μM) were incubated in 100 mM so-
dium acetate buffer pH 4.85 at 50°C, 60°C, 65°C and 70°C
in a PCR thermocycler. Aliquots were withdrawn at differ-
ent times and incubated at 4°C for 20 min. Endoglucanase
activity was measured at 50°C using MU-cellobiose as de-
scribed above. The enzyme half-life was calculated by fit-
ting the activity data to exponential or linear functions. All
experiments were carried out in duplicate. All experiments
were carried out using purified enzymes.
Cloning, expression and purification of T. reesei
endoglucanase I in N. crassa
T. reesei EGI and engineered mutants were expressed in
N. crassa as described previously [33]. The wild-type
TrEGI gene was amplified from T. reesei gDNA. The
engineered TrEGI mutants were constructed using site-
directed mutagenesis kit from Stratagene as described
above. TrEGI was purified from culture supernatant in a
series of steps. TrEGI was precipitated from the culture
supernatant with 65% ammonium sulfate. The super-
natant was spun down and the precipitated proteins
were resuspended 20 mM Tris–HCl pH 7 buffer and
desalted using HiPrep 26/10 desalting column with
20 mM Tris–HCl pH 7 as the running buffer. The pro-
tein was then concentrated and loaded on Mono Q col-
umn and TrEGI was eluted using 20 mM Tris–HCl
pH 7 buffer between 25–75 mM NaCl. TrEGI contain-
ing fractions were pooled and further polished using size
exclusion chromatography to give pure protein.
Cloning, expression and purification of Trichoderma
reesei endoglucanase I in T. reesei
For production of T. reesei EGI and engineered mutants
a EGI expression vector was constructed by introducing
the EGI gene followed by the N. crassa cbhI terminatorbehind the cdna1 promoter in pPcdna1 expression plasmid
(generous gift from Bernhard Seiboth) [41]. Transformation
of T. reesei by electroporation was adapted as described
previously [42]. Spores of T. reesei QM9414 were harvested
from a 90 mm potato dextrose agar (PDA) plate and sus-
pended in 1.1 M ice cold sorbitol. Spores were washed
twice with 1.1 M ice cold sorbitol, pelleted at 800xg for
4 min, and then re-suspended in 100 uL of 1.1 M ice cold
sorbitol. Two micrograms of purified PCR product of the
expression cassette using the primers 5′- GGATCCGA
GAGCTACCTTACATC -3′ and 5′- CGAACTACCTCG
CGAAACTCG -3′ was added to the spore suspension and
incubated on ice for 30 min. Electroporation was con-
ducted using a Gene Pulser Xcell (Bio-Rad Laboratories,
Inc., Hercules, CA) in 1 mm gap cuvette at 1.6 kV, 600Ω
and 25 μF. Immediately following electroporation, 900 μL
of 1.1 M ice cold sorbitol was added and gently mixed. The
spore suspension was then added to 9 mL of YPD (1%
(w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) dextrose)
and incubated for 12 hr at room temperature. Spores were
pelleted at 800xg for 4 min, re-suspended in 1 mL of 1.1 M
sorbitol, and plated using the overlay method onto
Mandels-Andreotti medium containing 200 μg/mL hygro-
mycin B. Both top and bottom agars contained hygromycin
B. Germinated spores were picked onto PDA slants con-
taining hygromycin B. Positive transformants were selected
by presence of EGI activity (AZO-CM-Cellulose Assay,
Megazyme, Ireland) in the supernatant after growth in
Mandels-Andreotti medium supplemented with 3% glu-
cose, in which QM9414 does not secrete native cellulases
[41,43] for 3–4 days. Culture broths were filtered through
glass microfiber filters (934-AH, Whatman) followed by
0.22 μm PES filters (Corning). TrEGI was purified from
culture supernatant as described above for N. crassaTrEGI.
Mass spectrometry of intact TrEGI protein
Mass Spectra were obtained via an Agilent 6510 Quadru-
pole Time-of-Flight (Q-TOF) mass spectrometer immedi-
ately following external mass calibration. TrEG1 protein
samples were diluted in water to a final concentration of
0.75 μM and 1 μL was injected using an autosampler. Sam-
ples were analyzed with an Agilent HPLC-chip cube using a
custom HPLC-chip (SPQ381) containing Zorbax 300A SB-
C3 (5 μm) separation (43 mm × 75 μm) and enrichment
(4 mm, 40 nL) columns. Proteins were eluted under a gradi-
ent of 3% to 95% Solvent B over 9 min. Solvent A was water
with 0.1% formic acid; Solvent B was acetonitrile with 0.1%
formic acid. Solvent reagents were of LC/MS grade. The Q-
TOF mass spectrometer was run under Extended Dynamic
Range (2GHz). The HPLC- Chip voltage was 1.85 kV, gas
temperature was 300°C, and drying gas flow was 4 L/min.
One spectra was acquired per second with 1000 ms/
spectrum using a mass range of 300–3,000 m/z. Data ana-
lysis was performed using Agilent Mass Hunter Qualitative
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gram peaks were deconvoluted using the maximum entropy
setting with a mass range of 20–80 kDa, mass step of 1 Da,
S/N threshold of 30, minimum consecutive charge states of
5, minimum protein fit score of 8, and an average mass of
90% peak height.
Glutaminyl Cyclase Treatment of S. cerevisiae Expressed
TrEGI
Lyophilized human glutaminyl cyclase was purchased
from Sino Biological (Daxing, China; 13752-H07B) and
reconstituted to 0.2 mg/mL. Cyclization was carried out
using 0.02 mg/mL cyclase and 50–100 μM TrEGI in
50 mM sodium phosphate pH 7.4 for 18–48 h at 30°C. N-
terminal edman sequencing was performed at University
of Califonia-Davis, proteomics core facility. All experi-
ments were carried out using purified TrEGI.
Differential scanning calorimetry
The apparent melting temperature of TrEGI (0.5–
1.0 mg/mL) in 50 mM sodium acetate, pH 4.85, was
measured using a TA Instruments NanoDSC. After
equilibration, a temperature schedule from 25°C to 80°C
was employed using a ramp rate of 1°C/min. Raw data
are presented for some TrEGI variants (Additional file
1: Figure S9) and the apparent melting temperature cor-
responds to the apex of each peak. For all TrEGI en-
zymes mentioned herein, melting was irreversible. All
experiments were carried out using purified enzymes.
Additional file
Additional file 1: Includes Figures S1-S9 and Tables S1-S2.
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